Log in or Sign up for Free to view tailored content for your specialty!
Biologics/Immunotherapy News
Panel OKs vaccination during dupilumab treatment
Vaccinations can be safe and effective during dupilumab treatment, according to the consensus of a panel published in Annals of Allergy, Asthma & Immunology.
Breath profile clusters predict response to biologic treatment in severe asthma
SAN DIEGO — Breath profile clusters can predict positive response to anti-IL5 or anti-IL5R alpha asthma treatment 1 month after initiation, according to an abstract presented at the American Thoracic Society International Conference.
Log in or Sign up for Free to view tailored content for your specialty!
Gene panel predicts response to mepolizumab among children with asthma
SAN DIEGO — The relative expressions of three genes associated with the airway predicted mepolizumab response among urban children with asthma, according to a study presented at the American Thoracic Society International Conference.
RNA interference silences RAGE with no detrimental effect on lungs in patients with asthma
SAN DIEGO — Study participants tolerated an inhaled therapeutic that silences the expression of a receptor for advanced glycation end-products in the lungs, according to a poster at the American Thoracic Society International Conference.
Mepolizumab safety profile comparable with placebo across 32 studies, multiple indications
SAN DIEGO — Rates of serious adverse events for patients on mepolizumab were comparable with those using placebo across 7,429 patient-years of exposure, according to a presentation at the American Thoracic Society International Conference.
Dupilumab associated with significant reductions in mucus plugging, volume
SAN DIEGO — Patients with asthma experienced significant reductions in mucus airway plugging and mucus volume with dupilumab, according to a presentation at the American Thoracic Society International Conference.
Mucus plugging may persist in severe asthma despite biologic treatment
SAN DIEGO — Patients with severe asthma often experience residual mucus plugging even with biologic treatment, according to a presentation at the American Thoracic Society International Conference.
FDA grants priority review to dupilumab for adolescents with CRSwNP
The FDA has accepted for priority review the supplemental biologics license application of dupilumab for adolescents with chronic rhinosinusitis with nasal polyps, Regeneron Pharmaceuticals Inc. and Sanofi announced in a press release.
Allergen immunotherapy associated with less nasal inhaler use in the short term
Patients treated with allergen immunotherapy for pollen used less nasal inhaler medication during their first 5 years of treatment than patients who did not use immunotherapy, according to a study published in Allergy.
Subcutaneous allergen immunotherapy reduces asthma risk, improves symptom control
Subcutaneous allergen immunotherapy for house dust mite reduced the number of prescriptions for allergic rhinitis and asthma medications, according to a study published in The European Journal of Allergy and Clinical Immunology.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read